Literature DB >> 8026271

Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study.

J J Chen1, C S Changchien, D I Tai, S S Chiou, C M Lee, C H Kuo.   

Abstract

Helicobacter pylori was found to be a promoter factor of peptic ulcer that has an incidence higher in patients with hepatic cirrhosis. To clarify the role between H. pylori and peptic ulcer in patients with hepatic cirrhosis, a serological test (ELISA test, HEL-p, AMRAD, Australia), was used to measure the presence of H. pylori of patients with hepatic cirrhosis. Within two years, 108 cirrhotic patients who had received a panendoscopic examination were enrolled in this study. There were 79 males and 27 females with a mean age of 53.2 years. Sixty-four cases had positive serum HBsAg and 44 had negative serum. The results showed that the prevalence of Helicobacter pylori in cirrhosis was 43.5% (47/108). There was no difference of HEL-p-positive rate between peptic ulcer and normal gastroduodenal mucosa (45.2% vs 46.1%, P > 0.05). According to this study, there appears to be no relation between peptic ulcer and H. pylori in patients with hepatic cirrhosis. The etiology of peptic ulcer in cirrhotic patients need further study.

Entities:  

Mesh:

Year:  1994        PMID: 8026271     DOI: 10.1007/bf02088065

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Sources of upper gastrointestinal hemorrhage in cirrhotic patients with esophageal varices.

Authors:  E D PALMER; I B BRICK
Journal:  N Engl J Med       Date:  1953-06-18       Impact factor: 91.245

2.  [Epidemiological: study on peptic ulcer and gastric cancer in the Chinese. Report 2].

Authors:  J L Sung; T H Wang; C S Chen; P H Lin; C H Chen
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1976-02

Review 3.  Peptic ulcer pathophysiology.

Authors:  H R Mertz; J H Walsh
Journal:  Med Clin North Am       Date:  1991-07       Impact factor: 5.456

4.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

5.  Prevalence of Campylobacter pylori and association with antral mucosal histology in subjects with and without upper gastrointestinal symptoms.

Authors:  C W Pettross; M D Appleman; H Cohen; J E Valenzuela; P Chandrasoma; L A Laine
Journal:  Dig Dis Sci       Date:  1988-06       Impact factor: 3.199

6.  Frequency of upper gastrointestinal lesions in patients with liver cirrhosis.

Authors:  C Sacchetti; M Capello; P Rebecchi; L Roncucci; G Zanghieri; A Tripodi; M Ponz de Leon
Journal:  Dig Dis Sci       Date:  1988-10       Impact factor: 3.199

7.  Helicobacter pylori-negative duodenal ulcer.

Authors:  Y M Nensey; T T Schubert; S D Bologna; C K Ma
Journal:  Am J Med       Date:  1991-07       Impact factor: 4.965

8.  Persistence of Campylobacter pyloridis despite healing of duodenal ulcer and improvement of accompanying duodenitis and gastritis.

Authors:  W M Hui; S K Lam; P Y Chau; J Ho; I Lui; C L Lai; A S Lok; M M Ng
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

9.  Peptic ulceration in patients with chronic liver disease.

Authors:  A P Kirk; J S Dooley; R H Hunt
Journal:  Dig Dis Sci       Date:  1980-10       Impact factor: 3.199

Review 10.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

View more
  13 in total

1.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

2.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

3.  Helicobacter pylori infection and pepsinogen levels have clinical significance in hypertension patients.

Authors:  Changqing Lu; Helei Jia; Aiguo Xu; Jianming Tang; Gang Xu; Wenbin Yue; Junjie Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Gastric epithelial cell proliferation in patients with liver cirrhosis.

Authors:  A Zullo; A Romiti; V Rinaldi; A Vecchione; C Hassan; S Winn; S Tomao; A F Attili
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Helicobacter pylori seroprevalence in patients with autoimmune hepatitis.

Authors:  Marilena Durazzo; Rinaldo Pellicano; Alberto Premoli; Mara Berrutti; Nicola Leone; Antonio Ponzetto; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

6.  Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis.

Authors:  Marilena Durazzo; Floriano Rosina; Alberto Premoli; Enrico Morello; Sharmila Fagoonee; Rosaria Innarella; Enrico Solerio; Rinaldo Pellicano; Mario Rizzetto
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

7.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

8.  Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.

Authors:  Edoardo Giannini; Alberto Fasoli; Federica Botta; Paola Romagnoli; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

Review 9.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

10.  Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma.

Authors:  Rinaldo Pellicano; Vincenzo Mazzaferro; Walter Franco Grigioni; Miguel Angel Cutufia; Sharmila Fagoonee; Lorenzo Silengo; Mario Rizzetto; Antonio Ponzetto
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.